TransMedics Group, Inc.
TransMedics Group, Inc., a commercial-stage medical technology company, engages in transforming organ transplant therapy for end-stage organ failure patients in the United States and internationally. The company offers Organ Care System (OCS), a portable…
Medical - Devices
US, Andover [HQ]
Ratios
8 Sheets · Starting from 2023Margins, Growth Rates In %
| Ratio | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | |
|---|---|---|---|---|---|---|---|---|---|
| Profitability | |||||||||
| Gross Margin | 12.34 | 27.81 | 44.05 | 58.73 | 64.88 | 69.92 | 69.84 | 63.73 | |
| Profit Margin | -387.58 | -270.96 | -182.50 | -142.12 | -112.13 | -146.11 | -38.77 | -10.36 | |
| Operating Margin | -370.20 | -265.79 | -155.47 | -125.42 | -102.91 | -130.29 | -33.64 | 0.20 | |
|
EPS Growth
|
- - | 13.25 | 14.58 | -91.87 | 50.85 | -37.93 | 23.13 | 37.40 | |
| EPS USD | -166.00 | -144.00 | -123.00 | -236.00 | -116.00 | -160.00 | -123.00 | -77.00 | |
| Return on Assets (ROA) | - - | -56.28 | -56.35 | -31.86 | -18.91 | -32.78 | -13.07 | -3.54 | |
| Return on Equity (ROE) | - - | 12.34 | 492.35 | -61.39 | -27.67 | -65.16 | -19.34 | -18.24 | |
| Return on Invested Capital (ROIC) | - - | 12.78 | -70.28 | -33.38 | -19.06 | -51.61 | -12.35 | 0.07 | |
| Solvency | |||||||||
| Equity Ratio | - - | -400 | - - | - - | - - | - - | - - | - - | |
| Debt/Assets | - - | 23.38 | 79.87 | 32.43 | 22.80 | 6.38 | 24.38 | 71.98 | |
| Debt/Equity | - - | -5.13 | -697.82 | 62.48 | 33.36 | 12.68 | 36.05 | 370.43 | |
| Debt/EBITDA | - - | 17.06 | -68.23 | -48.78 | -40.74 | 42.12 | 411.93 | 1,382.49 | |
|
Debt/Capitalization
|
- - | -5.41 | 116.73 | 38.45 | 25.01 | 11.25 | 26.50 | 78.74 | |
| Long-Term Debt/Capitalization | - - | -4.23 | 116.73 | 38.45 | 25.01 | 11.25 | 26.08 | 78.68 | |
| Interest Debt per Share USD | - - | 0.67 | 1.89 | 2.71 | 1.56 | 0.45 | 2.41 | 15.96 | |
| Debt Growth | - - | - - | 289.16 | 1.41 | 1.50 | -75.17 | 685.16 | 663.74 | |
| Liquidity | |||||||||
| Current Ratio | - - | 312.29 | 277.18 | 620.55 | 1,235.51 | 510.82 | 1,066.29 | 929.58 | |
| Quick Ratio | - - | 234.77 | 188.63 | 541.40 | 1,115.46 | 423.38 | 966.96 | 834.43 | |
| Cash Ratio | - - | 109.51 | 161.24 | 124.68 | 206.93 | 110.08 | 850.27 | 718.70 | |
| Operating Cash Flow Ratio | - - | -200 | -200 | -200 | -200 | -100 | -100 | - - | |
| Turnover | |||||||||
| Inventory Turnover | - - | 69.60 | 78.51 | 86.85 | 75.45 | 61.26 | 136.80 | 198.10 | |
| Receivables Turnover | - - | 830.81 | 378.62 | 359.87 | 373.53 | 509.98 | 338.49 | 380.05 | |
| Payables Turnover | - - | 157.84 | 154.30 | 134.41 | 746.60 | 136.87 | 843.67 | 689.08 | |
|
Asset Turnover
|
- - | 20.77 | 30.88 | 22.42 | 16.86 | 22.43 | 33.72 | 34.22 | |
| Fixed Turnover | - - | 312.53 | 374.70 | 492.57 | 539.31 | 192.90 | 383.77 | 133.87 | |
| Coverage | |||||||||
| Interest Coverage | -2,347.91 | -1,905.41 | -744.01 | -680.06 | -662.08 | -1,017.76 | -843.72 | 4.49 | |
| Asset Coverage | - - | 300 | - - | 200 | 400 | 1,200 | 300 | 100 | |
| Cash Flow Coverage (CFGR) | - - | -266.97 | -77.17 | -94.55 | -87.33 | -335.47 | -67.82 | -2.56 | |
| EBITDA Coverage | -2,300 | -1,700 | -700 | -600 | -600 | -1,000 | -800 | - - | |
| Dividend Coverage | - - | - - | - - | - - | - - | - - | - - | - - | |
| Time Interest Earned (TIE) | - - | - - | - - | - - | - - | - - | - - | 100 | |
| Market Prospects | |||||||||
| Dividend Yield | - - | - - | - - | - - | - - | - - | - - | - - | |
| Earnings Yield | -7.43 | -6.43 | -5.52 | -12.70 | -5.85 | -8.36 | -1.99 | -0.98 | |
|
Price/Earnings (P/E)
|
-1,345.23 | -1,554.68 | -1,811.51 | -787.16 | -1,709.98 | -1,196.74 | -5,035.01 | -10,254.90 | |
| Price/Earnings Growth (PEG) | - - | 117.31 | 124.22 | -8.57 | 33.63 | -31.55 | 217.73 | 274.21 | |
|
Price/Book (P/B)
|
- - | -191.87 | -8,919.02 | 483.21 | 473.17 | 779.82 | 973.57 | 1,870.67 | |
| Price/Tangible Book (P/TB) | - - | -191.87 | -8,919.02 | 483.21 | 473.17 | 779.82 | 973.57 | 1,870.67 | |
| Price/Sales (P/S) | 5,213.89 | 4,212.50 | 3,306.01 | 1,118.74 | 1,917.33 | 1,748.52 | 1,951.91 | 1,062.23 | |
|
Price/Cash Flow (P/CF)
|
-1,342.78 | -1,401.55 | -1,656.18 | -817.90 | -1,624.27 | -1,833.21 | -3,981.57 | -19,700.62 | |
| Price/Free CF (P/FCF) | -1,265.22 | -1,385.77 | -1,629.96 | -813.74 | -1,600.21 | -1,634.00 | -3,160.27 | -1,336.16 | |
| Price/Operating CF (P/OCF) | -1,342.78 | -1,401.55 | -1,656.18 | -817.90 | -1,624.27 | -1,833.21 | -3,981.57 | -19,700.62 |